BioTech & SmartPharma
Sector challenges
Sector challenges
The Biotech and SmartPharma sectors continue to develop rapidly. They look set to bring major advances in personalized therapies, early diagnosis, predictive medicine and optimizing the drug value chain – and considerable potential for improving human health and solving complex medical problems.
R&D
Drug Discovery
Biomanufacturing
Technology Platforms
Therapeutic Innovations
Life Science Tools
Performances
BioTech & SmartPharma performance in France
75%
of total business expenditure remains devoted to R&D
31%
of companies filed patents in 2025
75%
of companies target international markets from the outset
€72M
raised in 2024
Our services
Discover how to transform your ambitions into success
Collaboration with WILCO
Companies shaping BioTech & SmartPharma
Your contact
Your contacts at WILCO
Elise Gaubert
Business Manager
Benjamin Ichou
Business Manager
Inès Pouradier Duteil
Program Manager
Entrepreneur Mentors
Entrepreneur Mentors for
BioTech & SmartPharma
Céline Aknine
Joël Crouzet
Jeremie Mariau
Dominique Dufour
